|
시장보고서
상품코드
2039060
비출혈 시장 : 적응증별, 제품 유형별, 유통 채널별, 지역별Epistaxis Market, By Indication, By Product Type, By Distribution Channel, By Geography |
||||||
비출혈 시장은 2026년에 12억 달러로 추정되며, 2033년까지 21억 달러에 이를 전망입니다. 또한 2026-2033년 CAGR은 4.8%를 나타낼 것으로 예측됩니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준 연도 | 2025년 | 시장 규모(2026년) | 12억 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR | 4.80% | 예측 금액(2033년) | 21억 달러 |
비출혈(코피)은 코의 점막에서 출혈을 일으키는 흔한 임상 증상입니다. 코피는 보통 전비출혈과 후비출혈로 분류됩니다. 전비출혈은 코의 앞쪽 비강 중격에서 출혈하는 것을 말하며, 일반적으로 키셀바흐 신경총으로 알려져 있습니다. 전비출혈은 급성 비출혈이라고도 하며, 다양한 의학적 치료로 치료할 수 있는 가장 흔한 유형의 비출혈입니다. 한편, 비강 안쪽, 목구멍 근처에서 발생하는 후비루는 비교적 드문 임상 증상이지만, 상당한 양의 출혈을 유발할 수 있습니다. 후비루는 다량의 출혈과 호흡곤란, 피로, 안면 창백, 흉통을 동반할 수 있습니다.
그러나 대부분의 코피는 생명을 위협하는 경우는 드물고, 양성이며 자연 치유되고 자발적이지만 재발하기 쉬운 질환입니다. 코피는 대기 중 습도 부족으로 인한 점막 건조, 고혈압, 코 종양, 특정 약물 복용, 흡연, 음주 등 다양한 요인에 의해 유발될 수 있습니다.
시장 역학
최근 몇 년 동안 고혈압과 고혈압증을 유발하는 심장 관련 질환의 발생률이 꾸준히 증가하고 있습니다. 고혈압은 비출혈의 주요 원인 중 하나이며, 그 유병률 증가는 세계 비출혈 시장의 성장을 이끄는 주요 요인 중 하나가 될 것으로 예측됩니다. 예를 들어, 세계보건기구(WHO)에 따르면 2019년 전 세계적으로 11억 3,000만 명이 고혈압을 앓고 있다고 합니다.
본 보고서의 주요 특징
- 이 보고서는 각 부문의 잠재적 수익 기회를 밝히고 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한, 시장 촉진 및 억제요인 및 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 업체들의 경쟁 전략 등에 대한 중요한 고찰을 제공합니다.
- 세계 비출혈 시장의 주요 기업 프로파일을 기업 개요, 제품 포트폴리오, 주요 특징, 재무 실적, 전략 등 다양한 파라미터를 기반으로 정리하여 수록하였습니다.
- 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형 업데이트, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- '세계 코피 시장' 보고서는 투자자, 제품 제조업체, 유통업체, 제품 공급업체, 연구 및 컨설팅 회사, 신규 시장 진출기업, 재무 분석가 등 다양한 이해관계자를 대상으로 합니다.
목차
제1장 분석 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 비출혈 시장 : 적응증별(2026년-2033년)
제5장 세계의 비출혈 시장 : 제품 유형별(2026년-2033년)
제6장 세계의 비출혈 시장 : 유통 채널별(2026년-2033년)
제7장 세계의 비출혈 시장 : 지역별(2026년-2033년)
제8장 경쟁 구도
제9장 섹션
LSH 26.06.04Epistaxis Market is estimated to be valued at USD 1.2 Bn in 2026 and is expected to reach USD 2.1 Bn by 2033, growing at a compound annual growth rate (CAGR) of 4.8% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 1.2 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 4.80% | 2033 Value Projection: | USD 2.1 Bn |
Epistaxis, also known as nose bleeding, is a common clinical condition that results in loss of blood from the tissue lining of the nose. Epistaxis is usually classified as anterior or posterior epistaxis. Anterior epistaxis is defined as the bleeding from anterior septum of the nose, which is usually known as Kiesselbach plexus. Anterior epistaxis is also known as acute epistaxis and is the most commonly observed type of epistaxis that can be cured through various medical treatments. On the other hand, posterior nosebleeds originating from the back of nasal package, near the throat are a relatively less common clinical condition, as it may result in significantly large amount of blood loss. The posterior nosebleeds lead to massive blood loss and difficulty in breathing that may result in fatigue, paleness, and chest pain.
However, most nosebleeds are rarely life threatening and are benign, self-limiting, spontaneous, but recurrent. Epistaxis can be caused due to various factors such as lack of humidity in the atmosphere that results in drying of mucosal tract, hypertension, nasal tumors, and also, due to consumption of certain drugs, smoking, and alcohol.
Market Dynamics
There has been a steady rise in incidence of heart-related disorders leading to hypertension and high blood pressure in the recent past. Hypertension is one of the major causes of epistaxis and the increase in its prevalence is expected to be one of the major factors driving growth of the global epistaxis market. For instance, according to the World Health Organization (WHO), in 2019, 1.13 billion people worldwide suffered from hypertension.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players operating in this market
- It profiles key players in the global epistaxis market based on the following parameters-company overview, financial performance, product portfolio, geographical presence, key developments, and strategies
- Key players covered as a part of this study include Smith & Nephew, Medline Industries, Inc., Bristol-Myers Squibb Pharma Company, Ciron Drugs, and King Pharmaceuticals, Inc.
- Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
- The global epistaxis market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for global epistaxis market, research and consulting firms, new entrants, and financial analysts
Market Segmentation
- By Indication
- Anterior Epistaxis
- Posterior Epistaxis
- By Product Type
- Vasoconstrictors
- Anesthetics
- Antibiotic Ointments
- Cauterizing Agents
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Regional Insights
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Smith & Nephew
- Medline Industries, Inc
- Bristol-Myers Squibb Pharma Company
- Ciron Drugs
- King Pharmaceuticals, Inc
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Indication
- Market Snippet, By Product Type
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Industry Trend
- Mergers and Acquisitions
- Technology Overview
- Regulatory Scenario
- Epidemiology
- New Product Approvals/Launches
- PEST Analysis
4. Global Epistaxis Market, By Indication, 2026 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026, 2029, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
- Anterior Epistaxis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Posterior Epistaxis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Epistaxis Market, By Product Type, 2026 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026, 2029, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
- Vasoconstrictors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Anesthetics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Antibiotic Ointments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Cauterizing Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Epistaxis Market, By Distribution Channel, 2026 - 2033 (USD Bn)
- Introduction
- Market Share Analysis, 2026, 2029, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Epistaxis Market, By Region, 2026 - 2033 (USD Bn)
- Introduction
- Market Share Analysis, 2026, 2029, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Regional Trends
- North America
- Market Size and Forecast, By Indication, 2026-2033, (USD Bn)
- Market Size and Forecast, By Product Type, 2026-2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)
- Market Size and Forecast, By Country, 2026-2033, (USD Bn)
- U.S.
- Canada
- Europe
- Market Size and Forecast, By Indication, 2026-2033, (USD Bn)
- Market Size and Forecast, By Product Type, 2026-2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)
- Market Size and Forecast, By Country, 2026-2033, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Indication, 2026-2033, (USD Bn)
- Market Size and Forecast, By Product Type, 2026-2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)
- Market Size and Forecast, By Country, 2026-2033, (USD Bn)
- China
- Japan
- India
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast, By Indication, 2026-2033, (USD Bn)
- Market Size and Forecast, By Product Type, 2026-2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)
- Market Size and Forecast, By Country, 2026-2033, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Market Size and Forecast, By Indication, 2026-2033, (USD Bn)
- Market Size and Forecast, By Product Type, 2026-2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)
- Market Size and Forecast, By Country, 2026-2033, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Indication, 2026-2033, (USD Bn)
- Market Size and Forecast, By Product Type, 2026-2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)
- Market Size and Forecast, By Country, 2026-2033, (USD Bn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Company Profiles
- Smith & Nephew
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Medline Industries, Inc
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Bristol-Myers Squibb Pharma Company
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Ciron Drugs
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- King Pharmaceuticals, Inc
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Analyst Views
- Smith & Nephew
9. Section
- References
- Research Methodology
- About us and Sales Contact
